Submission of unaudited standalone and consolidated financial results for the quarter ended on 30.06.2026 as approved by The board of the directors in its meeting held on 06.08.2026
RESULTS
▼ Concern Flagged
HIGH RISK
📅 Filed on BSE: 06 Aug 2026, 04:54 PM IST · BSE ID: 3af1b069-e7e8-4415-904d-fb71a2029977
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported its latest quarterly financial results, showing a loss, and announced several changes to its top management team.
🤖 AI Summary
- Medi Caps board approved unaudited standalone and consolidated financial results for the quarter ended 30.06.2026.
- Standalone Net Loss for the quarter ended 30.06.2026 was -58.96 Lacs.
- Mrs. Saloni Garg appointed as Additional Director and Whole Time Woman Director for three years.
- Mr. Akshit Garg appointed as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) effective 07.08.2026.
- Re-appointment of Mr. Alok K. Garg as Chairman cum Managing Director for three years approved.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Revenue from Operation Q1 FY27
10.49 Lacs
Not comparable — limited prior period data.
Standalone Total Income Q1 FY27
10.86 Lacs
Not comparable — limited prior period data.
Standalone Profit/(Loss) for the period Q1 FY27
-58.96 Lacs
Not comparable — limited prior period data.
Standalone Earnings per equity share (Basic) Q1 FY27
-0.47 Rs.
Not comparable — limited prior period data.
🏢 How This Affects the Company
Medi Caps reported a standalone net loss of -58.96 Lacs for the quarter ended 30.06.2026, indicating continued operational losses. Total income for the standalone entity was 10.86 Lacs for the same period.
Key management appointments, including a Whole Time Woman Director and a new CFO, are effective from August 2026, which reorganizes leadership roles. The re-appointment of the Chairman cum Managing Director provides continuity in top leadership.
The recurring net loss in the standalone financial results indicates an ongoing financial performance challenge. Dependence on other income for a significant portion of total income suggests potential volatility.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will be required to approve the appointments of Mrs. Saloni Garg and the re-appointment of Mr. Alok K. Garg at the ensuing 43rd Annual General Meeting.
👤
Who Is Affected
All shareholders will be affected by the company's financial performance, specifically the net loss of -58.96 Lacs, and decisions regarding board composition and leadership continuity.
🔍
Management Signal
The management's decision to appoint new key personnel and re-appoint the Chairman indicates an intent to maintain leadership continuity and potentially re-align strategic direction.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
43rd Annual General Meeting on 22nd September 2026 for approval of director appointments.
Q2 FY27 financial results for trends in revenue and profitability.
Any further disclosures regarding operational strategies from the new management.
HIGH RISK
The company reported consistent net losses and very low operational revenue, indicating significant financial challenges.
💡 Investor Takeaway
Medi Caps Ltd. reported a standalone net loss of -58.96 Lacs for the quarter ended 30.06.2026, an increase from -39.75 Lacs in the prior year's comparable quarter. Key management changes include a new Whole Time Woman Director and CFO appointments, along with the Chairman cum Managing Director's re-appointment.
⚖️ Strengths & Concerns
⚠️ Concerns
- Standalone Net Profit/(Loss) for Q1 FY27 was -58.96 Lacs, a continued loss from -39.75 Lacs in Q1 FY26 and -31.29 Lacs in Q4 FY26.
- Standalone Revenue from Operation for Q1 FY27 was 10.49 Lacs, showing limited operational revenue compared to total expenses of 69.82 Lacs.
❓ Frequently Asked Questions
What was Medi Caps Ltd.'s standalone net profit/loss for the quarter ended 30.06.2026?
Medi Caps Ltd. reported a standalone net loss of -58.96 Lacs for the quarter ended 30.06.2026.
Who was appointed as the Chief Financial Officer (CFO) of Medi Caps Ltd.?
Mr. Akshit Garg was appointed as the Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of Medi Caps Ltd. effective 07.08.2026.
Who was appointed as the Whole Time Woman Director of Medi Caps Ltd.?
Mrs. Saloni Garg was appointed as an Additional Director and Whole Time Woman Director of Medi Caps Ltd. for a period of three years, effective 07.08.2026.
What was Medi Caps Ltd.'s standalone revenue from operations for Q1 FY27?
Medi Caps Ltd.'s standalone revenue from operations for the quarter ended 30.06.2026 was 10.49 Lacs.
Questions based on this BSE filing only. For information purposes.